Auxier Asset Management Has Cut Its Quest Diagnostics (DGX) Holding; Marcus & Millichap (MMI) Shorts Increased By 22.75%

November 15, 2017 - By Richard Conner

Auxier Asset Management decreased Quest Diagnostics Inc. (DGX) stake by 6.98% reported in 2017Q2 SEC filing. Auxier Asset Management sold 3,200 shares as Quest Diagnostics Inc. (DGX)’s stock rose 10.72%. The Auxier Asset Management holds 42,645 shares with $4.74M value, down from 45,845 last quarter. Quest Diagnostics Inc. now has $12.60 billion valuation. It closed at $92.42 lastly. It is down 39.04% since November 15, 2016 and is uptrending. It has outperformed by 22.34% the S&P500.

Marcus & Millichap (NYSE:MMI) had an increase of 22.75% in short interest. MMI’s SI was 1.16M shares in November as released by FINRA. Its up 22.75% from 943,500 shares previously. With 120,100 avg volume, 10 days are for Marcus & Millichap (NYSE:MMI)’s short sellers to cover MMI’s short positions. It closed at $30.65 lastly. It is down 0.91% since November 15, 2016 and is downtrending. It has underperformed by 17.61% the S&P500.

Among 20 analysts covering Quest Diagnostics (NYSE:DGX), 7 have Buy rating, 2 Sell and 11 Hold. Therefore 35% are positive. Quest Diagnostics had 54 analyst reports since August 4, 2015 according to SRatingsIntel. On Tuesday, January 3 the stock rating was upgraded by Mizuho to “Buy”. Piper Jaffray maintained the stock with “Hold” rating in Thursday, October 19 report. The firm has “Hold” rating by Credit Suisse given on Thursday, September 28. The stock of Quest Diagnostics Inc (NYSE:DGX) earned “Market Perform” rating by Wells Fargo on Friday, October 16. The stock of Quest Diagnostics Inc (NYSE:DGX) has “Neutral” rating given on Wednesday, August 31 by Mizuho. The firm has “Buy” rating given on Monday, June 26 by Raymond James. The rating was maintained by RBC Capital Markets on Friday, October 23 with “Sector Perform”. The rating was maintained by Mizuho with “Neutral” on Friday, October 21. The firm has “Hold” rating by SunTrust given on Friday, October 13. On Monday, April 24 the stock rating was maintained by Raymond James with “”.

Investors sentiment decreased to 0.99 in 2017 Q2. Its down 0.05, from 1.04 in 2017Q1. It dropped, as 38 investors sold DGX shares while 200 reduced holdings. 78 funds opened positions while 158 raised stakes. 113.89 million shares or 2.51% less from 116.82 million shares in 2017Q1 were reported. Hussman Strategic Advsr owns 75,000 shares for 1.85% of their portfolio. Suntrust Banks Inc, Georgia-based fund reported 24,186 shares. Pub Sector Pension Investment Board reported 0.01% in Quest Diagnostics Inc (NYSE:DGX). Moors Cabot has invested 0.04% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). 56,676 are owned by Comerica Bank. 307,500 are held by Rhumbline Advisers. Ubs Asset Americas has invested 0% in Quest Diagnostics Inc (NYSE:DGX). Gemmer Asset Lc has invested 0% in Quest Diagnostics Inc (NYSE:DGX). Amer Century Cos owns 1.74 million shares for 0.2% of their portfolio. John G Ullman Assocs reported 49,539 shares. Ls Inv Ltd Liability Company has invested 0.11% in Quest Diagnostics Inc (NYSE:DGX). Bahl & Gaynor accumulated 16,103 shares. Washington Tru Financial Bank has 0.01% invested in Quest Diagnostics Inc (NYSE:DGX) for 500 shares. Boston Advisors Lc holds 177,972 shares. Apg Asset Management Nv holds 0.21% or 1.05 million shares.

Analysts await Quest Diagnostics Inc (NYSE:DGX) to report earnings on January, 25. They expect $1.40 earnings per share, up 6.87% or $0.09 from last year’s $1.31 per share. DGX’s profit will be $190.87 million for 16.50 P/E if the $1.40 EPS becomes a reality. After $1.39 actual earnings per share reported by Quest Diagnostics Inc for the previous quarter, Wall Street now forecasts 0.72% EPS growth.

Marcus & Millichap, Inc. is a brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services. The company has market cap of $1.17 billion. The Firm offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory and consulting services. It has a 19.91 P/E ratio. It provides its financing services through Marcus & Millichap Capital Corporation, which is a broker of debt financing for commercial properties.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.